BIODESIX, INC. (BDSX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -27.77M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-27.77M | (m) |
| 2026-03-31 | (m) | $-31.96M | (m) |
| 2025-12-31 | (m) | $-35.27M | (m) |
| 2025-09-30 | (m) | $-39.54M | (m) |
| 2025-06-30 | (m) | $-41.08M | (m) |
| 2025-03-31 | (m) | $-40.42M | (m) |
| 2024-12-31 | (m) | $-42.93M | (m) |
| 2024-09-30 | (m) | $-43.82M | (m) |
| 2024-06-30 | (m) | $-44.51M | (m) |
| 2024-03-31 | (m) | $-47.06M | (m) |
| 2023-12-31 | (m) | $-52.15M | (m) |
| 2023-09-30 | (m) | $-63.34M | (m) |
| 2023-06-30 | (m) | $-66.09M | (m) |
| 2023-03-31 | (m) | $-68.56M | (m) |
| 2022-12-31 | (m) | $-65.45M | (m) |
| 2022-09-30 | (m) | $-58.39M | (m) |
| 2022-06-30 | (m) | $-56.21M | (m) |
| 2022-03-31 | (m) | $-51.78M | (m) |
| 2021-12-31 | (m) | $-43.16M | (m) |
| 2021-09-30 | (m) | $-34.41M | (m) |
| 2021-06-30 | (m) | $-31.74M | (m) |
| 2021-03-31 | (m) | $-28.61M | (m) |
| 2020-12-31 | (m) | $-31.35M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) |
| 2019-12-31 | (m) | $-30.73M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |